Our keynote speaker was Professor Bloor, Clinical Director of Haematology at Manchester University. Professor Bloor discussed trials from a doctor’s perspective and answers questions in the subsequent Q & A.
28th November 2020
Our keynote speaker was Professor Bloor, Clinical Director of Haematology at Manchester University. Professor Bloor discussed trials from a doctor’s perspective and answers questions in the subsequent Q & A.
We also heard from Robin Edwards who spoke from a patient’s perspective.
Dominic Pivonka, Head of Health Technology Assessments and Pricing at AbbVie Ltd gave the pharmaceutical industry’s perspective on getting new medicines into the clinic.
Rob Coster, National Programme of Care Manager – Blood and Infection, Specialised commissioning at NHS England gave the NHS perspective on commissioning new treatments.
Who we are
We are a patient led UK charity, our mission is to support and empower CLL patients, their families and their carers.
Read moreOur 24 hour membership telephone number is: 0800 977 4396
About CLL
CLL is a malignancy of B lymphocytes, one of several types of cells of the immune system.
Read moreAbout CLL
Donate
Donate to support our CLL community
Donate nowHealthUnlocked
Connect to others who understand
Open in a new tabThis page was last reviewed 16th June 2021. Next review June 2024
Send us feedback about this pageSend us feedback about this page
Help us to ensure we deliver the best content we can by giving us feedback about this page, good or bad. Please provide an email address if you would like us to respond to your feedback.
"*" indicates required fields